Study Examines Benefits, Risks to Cognitive Function of HRT for Women Ages 50 to 55 Years
JAMA - Journal of the American Medical AssociationPostmenopausal hormone therapy with conjugated equine estrogens (CEEs) was not associated with overall sustained benefit or risk to cognitive function when given to women ages 50 to 55 years, according to a report published Online First by JAMA Internal Medicine, a JAMA Network publication.